Scinovex
articleTop 1% cited

Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

The American Journal of Cardiology · 1998 · Vol. 81(5) · pp. 582–587
Peter J.H. JonesStephanie D. KafonekIrene LauroraDonald B. Hunninghake
Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyFluvastatinPravastatinLovastatinAtorvastatinSimvastatinHMG-CoA reductaseCholesterolMedicineHydroxymethylglutaryl-CoA reductaseStatin

MeSH terms

AtorvastatinFluvastatinAdolescentAdultAgedAged, 80 and overAnticholesteremic AgentsFatty Acids, MonounsaturatedFemaleHeptanoic AcidsHumansHypercholesterolemiaIndolesCholesterol, LDLLovastatin
Citations
1,074
FWCI
71.53
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.